إسرائيل -
العربية -
Ministry of Health
تيڤاعديرم
teva pharmaceutical indust.ltd - diflucortolone valerate 0.1 %; isoconazole nitrate 1 % - cream - diflucortolone - for the local treatment of inflammatory skin conditions accompanied by secondary fungal infections.
إسرائيل -
العربية -
Ministry of Health
چينوتروپين ١٢
pfizer pharmaceuticals israel ltd - somatropin recombinant 36 iu/ml - lyophilized powder for injection - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.
إسرائيل -
العربية -
Ministry of Health
لوثيماكس
salomon,levin & elstein ltd - loteprednol etabonate 5 mg / 1 ml - ophthalmic suspension - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po
إسرائيل -
العربية -
Ministry of Health
كسالاتان
pfizer pharmaceuticals israel ltd - latanoprost 50 mcg/ml - eye drops - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.
إسرائيل -
العربية -
Ministry of Health
كسالاكوم قطره للعينين
pfizer pharmaceuticals israel ltd - latanoprost 50 mcg/ml; timolol as maleate 5 mg/ml - eye drops - other antiglaucoma preparations - reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.
